Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
NextCure, Inc. (NXTC) had Stock-Based Compensation of $2.99M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-9.44M |
|
-- |
|
-- |
|
$9.76M |
|
$-9.76M |
|
$0.32M |
|
$-9.44M |
|
$-9.44M |
|
$-9.44M |
|
$-9.44M |
|
$-9.44M |
|
$-9.44M |
|
$-9.76M |
|
$-9.44M |
|
2.84M |
|
2.84M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$43.75M |
|
$3.27M |
|
$6.44M |
|
$50.18M |
|
$10.57M |
|
-- |
|
$4.67M |
|
$15.24M |
|
$34.94M |
|
$34.94M |
|
$34.94M |
|
3.51M |
|
| Cash Flow Statement Financials | |
$-49.61M |
|
$25.56M |
|
$22.31M |
|
$27.73M |
|
$25.98M |
|
$-1.75M |
|
|
Stock-Based Compensation |
$2.99M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-49.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-27.00% |
|
-27.00% |
|
-18.80% |
|
-27.00% |
|
$9.97 |
|
$-17.45 |
|
$-17.45 |
|